Cell Secretome: Basic Insights and Therapeutic Opportunities for CNS Disorders.
Ontology highlight
ABSTRACT: Transplantation of stem cells, in particular mesenchymal stem cells (MSCs), stands as a promising therapy for trauma, stroke or neurodegenerative conditions such as spinal cord or traumatic brain injuries (SCI or TBI), ischemic stroke (IS), or Parkinson's disease (PD). Over the last few years, cell transplantation-based approaches have started to focus on the use of cell byproducts, with a strong emphasis on cell secretome. Having this in mind, the present review discusses the current state of the art of secretome-based therapy applications in different central nervous system (CNS) pathologies. For this purpose, the following topics are discussed: (1) What are the main cell secretome sources, composition, and associated collection techniques; (2) Possible differences of the therapeutic pot
SUBMITTER: Pinho AG
PROVIDER: S-EPMC7169381 | biostudies-literature | 2020 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA